PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 176 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $835,000 | -37.2% | 100,000 | 0.0% | 0.20% | -37.0% |
| Q2 2023 | $1,330,000 | -4.3% | 100,000 | -16.7% | 0.32% | -10.1% |
| Q1 2023 | $1,389,600 | +41.6% | 120,000 | 0.0% | 0.36% | +33.6% |
| Q4 2022 | $981,600 | +20.7% | 120,000 | -14.3% | 0.27% | +9.4% |
| Q3 2022 | $813,000 | +31.3% | 140,000 | 0.0% | 0.24% | +34.6% |
| Q2 2022 | $619,000 | -51.4% | 140,000 | 0.0% | 0.18% | -46.9% |
| Q1 2022 | $1,274,000 | -59.8% | 140,000 | -9.7% | 0.34% | -59.5% |
| Q4 2021 | $3,171,000 | -31.1% | 155,000 | -13.9% | 0.85% | -42.1% |
| Q3 2021 | $4,599,000 | -26.9% | 180,000 | 0.0% | 1.46% | -23.8% |
| Q2 2021 | $6,295,000 | +5.0% | 180,000 | 0.0% | 1.92% | +0.2% |
| Q1 2021 | $5,996,000 | -42.2% | 180,000 | -55.0% | 1.92% | -40.1% |
| Q4 2020 | $10,376,000 | +49.6% | 400,000 | -43.1% | 3.20% | +26.6% |
| Q3 2020 | $6,938,000 | – | 702,937 | – | 2.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAVENS ADVISORS LLC | 638,000 | $4,613,000 | 4.46% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 6,064,035 | $43,843,000,000 | 3.34% |
| STANSBERRY ASSET MANAGEMENT, LLC | 1,022,262 | $7,391,000 | 2.54% |
| HighVista Strategies LLC | 378,479 | $2,736,000 | 2.23% |
| Versor Investments LP | 3,117,632 | $22,540,000 | 2.14% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 1,627,677 | $11,768,000 | 1.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,110,666 | $8,030,000 | 1.71% |
| Magnetar Financial LLC | 8,217,938 | $59,416,000 | 1.53% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 6,072,459 | $43,905,000 | 1.45% |
| WATER ISLAND CAPITAL LLC | 7,247,354 | $52,398,000 | 1.43% |